+39 02 610346.1 - info@newron.com

Latest press releases

  • 21Nov
    Safinamide regulatory process in Europe on track


  • 16Sep
    Newron Pharmaceuticals reports half-year results 2014


  • 29Jul
    Refusal to File letter received from US FDA for safinamide, based on organization and navigation problems


  • 11Jul
    Newron shares to be included in the SXI Life Sciences® and the SXI Bio+Medtech® indices


  • 8Jul
    Newron establishes US operations


  • 29May
    Safinamide New Drug Application (NDA) submitted to the US Food and Drug Administration (FDA)


View All

Newron share price


  • 9Feb
    17th Annual BIO CEO & Investor Conference

    February 9-10, 2015  - The Waldorf Astoria, New York City, US


  • 24Nov
    German Equity Forum

    November 24-26, 2014 - Frankfurt-am-Main - Germany

  • 5Nov
    Vontobel Healthcare Tour

    November 5, 2014 - Zürich, Switzerland

View Event Calendar